The Cost-Effectiveness of Vedolizumab for Inflammatory Bowel Disease: A Review of the Current Literature

The United States spends a greater share per gross domestic product on health care than any other developed country in the world. Cost-conscious, high-value care has an important role in the practice of medicine. Inflammatory bowel disease (IBD) affects 1.6 million people in the United States and is...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Gastroenterol Hepatol (N Y)
Prif Awduron: Schneider, Yecheskel, Saumoy, Monica, Cohen-Mekelburg, Shirley, Steinlauf, Adam F., Scherl, Ellen J.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Millennium Medical Publishing 2016
Pynciau:
Column
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5114504/
https://ncbi.nlm.nih.gov/pubmed/27917076
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg